UK markets closed

HLK Biotech Holding Group, Inc. (AMHD)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00010.0000 (0.00%)
At close: 01:40PM EST

HLK Biotech Holding Group, Inc.

2612 Granby Street
Norfolk, VA 23517
United States

IndustryDrug Manufacturers—Specialty & Generic
Full-time employees

Key executives

NameTitlePayExercisedYear born
Dr. Anna PetinovaInterim VP of Admin., Interim VP of Fin., Treasurer and DirectorN/AN/A1964
Mr. Hank MiddenVP - OperationsN/AN/A1942
Mr. John GernanntHead of Investor & PR IssuesN/AN/AN/A
Mr. Peter R. N. MaharajVP - Marketing and Pres - Southern HardwoodsN/AN/A1966
Mr. Thomas CripeSr. VP of Bus. & Technology Devel.N/AN/AN/A
Mr. Tyler MacallisterControllerN/AN/AN/A
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


HLK Biotech Holding Group, Inc., through its subsidiaries, produces and sells biodiesel. It also acquires real estate properties. The company was formerly known as Amelot Holdings, Inc. and changed its name to HLK Biotech Holding Group, Inc. in February 2018. HLK Biotech Holding Group, Inc. is headquartered in Norfolk, Virginia.

Corporate governance

HLK Biotech Holding Group, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.